Dr. Wayne Grant Carter received his Honours degree in Biochemistry with Nutrition from the University of Southampton He then completed a PhD at the University of Southampton studying the molecular signalling cascade elicited by insulin His PhD studies encompassed the design and synthesis of peptide targets for insulinstimulated kinases and their utilisation to dissect signalling events downstream of insulin binding to its receptor He purified peptide targets by reversephase high performance liquid chromatography RPHPLC and assayed signalling kinases utilising radiolabelled phosphorus to determine phosphorylation sites by both radiosequencing and phosphopeptide mapping eg Carter et al 1995 1996 Subsequent postdoctoral studies at the Babraham Institute Cambridge; Imperial College London; University of California at Irvine; and University of Oxford were also directed toward the regulation of cellular signalling mechanisms through posttranslational modification of proteins and how these influence inflammation and homeostasis Dr Carter then spent one year working for Mobious Genomics Exeter assisting with the biophysical development of novel DNA sequencing devices before he joined the staff at the University of Nottingham where he is currently a Principal Investigator and Lecturer for a new course in Healthcare Sciences founded at the University of Nottingham site within the Royal Derby Hospital Derby His previous and current research pioneered the use of proteomic techniques coupled to novel imaging of radiolabels to detect and purify proteins that are modified posttranslationally eg Vigneswara et al 2006; Carter et al 2007; Tarhoni et al 2008; Carter Aswad 2008; Kharbanda et al 2009; Carter et al 2010 He has received external grant funding for his academic studies from research funding bodies that include the Wellcome Trust UK and the National Institutes of Health USA and also from commercial sources that include Syngenta UK His professional affiliations include The Physiological Society the Royal Society of Chemistry the Biochemical Society the British Toxicological Society the British Neuroscience Association and the American College of Sports Medicine He has peerreviewed manuscripts for numerous academic journals including: FEBS Letters Brain Research Environmental Toxicology Biochemica et Biophysica Acta American Journal of Physiology Journal of Chromatography B International Journal of Biomedical Science World Journal of Cardiology and Toxicological Sciences and is currently an Editorial Board member for the World Journal of Biological Chemistry as well as Executive Editor for Europe for the Journal of Chromatography Separation Techniques

Lakshmy Nair is a Research Scientist in the Medication Delivery department of Baxter Healthcare where she is responsible for analytical method development/validation to support a number of formulation products In her role she has led the analytical team to develop numerous analytical methods using HPLC/UHPLC with various detection mechanisms such as UV ELSD CAD and MS; for surfactants polymers and drug analyses Before joining Baxter she was a Senior Research Scientist at Apotex Corporation and prior to that an Instrumentation Product Development Chemist at Alltech Associate currently known as Grace Davison At Alltech Lakshmy pioneered HPLC and ion chromatography IC and was involved in developing many ionexchange stationary phases suppressors conductivity detectors and sample preparation products Lakshmy has 18 publications in various peer reviewed journals one patent and presented approximately 50 papers in various symposiums in the field of liquid chromatography She has been invited to speak at various seminars and has been a guest reviewer for Journal of Chromatography and Journal of Pharmaceutical and Biomedical Analysis Lakshmy has been a member of the abstract screening committee for the APQ Analysis and Pharmaceutical Quality session of annual AAPS meetings Her areas of expertise are various liquid chromatographic separation techniques including reversed phase normal phase sizeexclusion ion exchange HILIC and UHPLC She is an expert in aerosolbased detectors suppressor based and nonsuppressor based conductivity detectors as well.

Sihe Wang PhD is head and director Section of Clinical Biochemistry; medical staff Departments of Clinical Pathology and Nephrology and Hypertension; and director Clinical Biochemistry Fellowship Training Program Cleveland Clinic Cleveland Ohio The Clinical Biochemistry Section performs 15 million tests annually and consists of an automated chemistry laboratory a special chemistry laboratory and various satellite laboratories including a blood gas laboratory Additionally he is clinical professor Cleveland State University where he lectures on special topics in clinical chemistry He received his PhD in pharmacy medicinal chemistry at the University of North Carolina at Chapel Hill He completed a postdoctoral fellowship in clinical chemistry at Duke University Medical Center Durham North Carolina Prior to his current position he was assistant professor at Northwestern University and director Clinical Chemistry Laboratory and Referred Testing Laboratory Children’s Memorial Hospital Chicago IllinoisDr Wang is a diplomate of the American Board of Clinical Chemistry and a fellow of the National Academy of Clinical Biochemistry He is a member of several professional organizations including the American Society for Mass Spectrometry and the American Association for Clinical Chemistry AACC He has served in many capacities in the AACC organizations including the chair of AACC Northeast Ohio Section in 2008 and 2009 and the president of North American Chinese Clinical Chemistry Association 20082009 Dr Wang currently serves as the secretary for the Pediatric and Maternal Fetal Division of AACC The AACC presented him with the 2005 and 2008 Clinical Chemist Recognition Award Dr Wang was also the recipient of the 2006 Lemuel J Bowie Young Investigator Award at the Chicago Section of the American Association of Clinical Chemistry AACC Dr Wang is the author of more than 75 clinical journal articles book chapters abstracts and meeting presentations He has also lectured in the US and around the world on variety of clinical chemistry topics He has been a principal investigator or coinvestigator in several trials to evaluate and validate new testing technologies and novel tests

DrNorio YasuiFurukori MD PhD now is an Associate professor of Neuropsychiatry Graduate School of Medicine Hirosaki University and a secretary of Japanese Society of Clinical Neuropsychopharmacology a committee member of Japanese Society of Clinical Neuropsychopharmacology Japanese Society of Clinical Pharmacology Japanese Research Society of Schizophrenia and Japanese Society of Psychiatry Diagnoses He got his PhD in Clinical Psychopharmacology at Hirosaki University And Dr Norio YasuiFurukori got the a Research Award Paul Janssen Award form Japanese Society of Clinical Neuropsychopharmacology in 2001 2002 2004 2005 2006 2007 2008 and 2010 and a Research Award form Hirosaki University in 1998 and 2006Currently Dr Norio YasuiFurukori’ researches focus on the clinical pharmacology in Neuropsychiatric disorders Dr Norio YasuiFurukori studies on drug metabolism and side effect of antipsychotics such as metabolic syndrome hyperprolactinemia and sexual dysfunction

John Gregory Marshall receivd PhD from University of Waterloo currently working as Associate Professor at Ryerson University.

Dr Zeping Hu has received his PhD in National University of Singapore during the period of 2003-2008. Currently he is working at Biological Separations Mass Spectrometry of Pacific Northwest National Laboratory He is serving as a reviewer of several reputed journals like Drug Metabolism Disposition Pharmaceutical Research Journal of Pharmaceutical Sciences Journal of Chromatography B Analytical Methods Current Pharmacogenomics and Personalized Medicine and Drug Healthcare and Patient Safety He has authored 15 research articles/books He is a member of American Association of Pharmaceutical Scientists Singaporean Society for Mass Spectrometry American Association for Cancer Research the Metabolomics Society and World Federation of Chinese Medicine Societies

Dr Shengmin Sang is an Associate Professor in the Center of Excellence for PostHarvest Technologies at North Carolina Agricultural and Technical State Univesity He is also an adjunct faculty in the Department of Chemical Biology School of Pharmacy at Rutgers University and in the Department of Food Bioprocessing and Nutritional Sciences at North Carolina State University He obtained his PhD degree as a natural product chemist from Shanghai Institute of Material Medicine Chinese Academy of Sciences in 1999 He has published 110 peerreviewed articles in reputable journals and 15 book chapters He has coedited a book titled “Herbs: Challenges in Chemistry and Biology” He has also received two US patents Dr Sang’s research has been supported by research grants from NIH US Department of Agriculture private foundations as well as private companies His outstanding research in the area of food and health was recognized by winning year 2007’s Young Scientist Award of the Agricultural and Food Chemistry Division of the American Chemical Society and year 2009’s Matthew Suffness Young Investigator Award which is currently the highest honor for an investigator in the first ten years of his independent research career in the American Society of Pharmacognosy

Dr. Adamec started his research career in the Institute of Microbiology of the Czech Academy of Sciences 1991 In 1992 Dr Adamec joined the PhD program at this Institute and his research was focused mainly on mechanisms of regulation of expression of stress proteins during cell differentiation After finishing his PhD in 1994 he spent two years in Department of Genetics at Yale University as a postdoctoral fellow working on research problems in metabolic diseases of mitochondrial origin In 1999 he joined a research group at the Mayo Clinic working on disease mechanisms in Friedreich’s ataxia In 2002 Dr Adamec accepted the invitation of the founders to assume the position of Senior Scientist at Beyond Genomics a biopharmaceutical company founded to discover and develop new drugs with Systems Biology approaches Currently he is a Research Associate Professor and a Lead Scientist for Proteomics and Metabolomics at the Bindley Bioscience Center at Purdue University Dr Adamec has authored more than 40 scientific journal publications He is also author of three book chapters multiple patents and associated editor Journal of integrated OMICS

QingYi Lu is an Associate Professor in the David Geffen School of Medicine University of California at Los Angeles Dr QingYi Lu has received her PhD in New York University and completed postdoctoral training in Rockefeller University She has authored more than 40 research articles She is a reviewer of 10 professional journals including Clinical Cancer Research and JAMA.

Dr. Dora Il’yasova started her scientific career at Moscow State University where she received MS in biochemistry She obtained PhD in Epidemiology at the Department of Epidemiology at the University of North Carolina at Chapel Hill UNCCH As a part of her dissertation she conducted a casecontrol study on rectal cancer and tea consumption in Moscow This study won the First prize in the 2001 Congress of Epidemiology the Abraham Lilienfield Award As a Fellow in the Cancer Control and Prevention Program Dr Il’yasova’s joined the Comprehensive Cancer Center at Wake Forest University CCCWFU to study the role of oxidative damage in the development of chronic conditions Her research focused on biomarkers of oxidative status Currently Dr Il’yasova works at Duke Comprehensive Cancer Center She conducts multiple studies examining the relationship between urinary biomarkers of oxidative status detection with different chronic disease outcomes The biomarkers are measured by liquid chromatography with tandem mass spectrometry Dr Il’yasova actively participated in development of these methods some of which has been clinically validated

Laboratory of Clinical Pharmacology and PharmacogeneticsDepartment of Infectious DiseasesUniversity of TorinoAmedeo di Savoia Hospital.

Dr Naushad has completed his PhD in Analytical Chemistry at the age of 26 years from Aligarh Muslim University India He has been selected as the post doctoral research fellow at Malaya University Malaysia Currently he is working as Assoc Professor in King Saud University Riyadh Saudi Arabia He has received the scholarships from UGC India California Washington DC and Michigan He is the author of more than 28 publications including book chapters and review papers His research area is Composite ion exchange materials Ion selective electrodes and Analytical separation techniques He is serving as an editorial board member and reviewer of several reputed scientific journals.

He has received his PhD in Chemistry at the University “La Sapienza” of Rome, Italy during the period  of 1970-75.  Currently,  he is working as full professor in the University “La Sapienza” of Rome. He is serving as an editorial member/referee of several reputed journals like Natural Product Reports, Plant Biosystem, Natural Products Communication, Analytical Letters and others. He has authored more than 100 research articles/books. He is a member of Italian Phytochemical Society (vice-president), SILAE, Italian Pharmacognosy Society. He has honored as consultant expert of EMA.

Laboratory of Clinical Pharmacology and PharmacogeneticsDepartment of Infectious DiseasesUniversity of TorinoAmedeo di Savoia Hospital.